Business Wire

Ares Management and Slate Asset Management to Acquire Polish Real Estate Portfolio Valued at Over €300 Million From Trei Real Estate

Share

Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global alternative investment manager, and Slate Asset Management (“Slate”), a global investor and manager focused on essential real estate and infrastructure, today announced that a joint venture between Ares Real Estate funds (“Ares Real Estate”) and Slate has agreed to acquire a portfolio of 36 properties in Poland (the “Portfolio”) from Trei Real Estate, an internationally active developer and asset manager. The Portfolio is valued at over €300 million.

The Portfolio comprises 36 recently developed and fully occupied convenience-led retail parks strategically located across major Polish metropolitan areas near large catchment populations. The assets are inflation-protected through CPI-linked lease agreements underpinned by tenants with strong covenants. Most of the Portfolio’s income is derived from large regional retailers and essential goods providers, including grocers and pharmacies.

“This transaction underlines our conviction in Polish real estate and the broader European retail sector, both of which are areas in which Ares has been investing for over two decades,” said Kevin Cahill, Partner and Head of European Diversified Investments in the Ares Real Estate Group. “We believe the Portfolio presents significant opportunities for additional value creation and we look forward to working closely with Slate to unlock its full potential.”

“This Portfolio of modern, high-quality properties is a natural fit for our income-focused essential real estate strategy, which specifically targets convenience and necessity-based retail and other mission-critical real estate across Europe,” said Sven Vollenbruch, Managing Director at Slate. “After years of studying the Polish market and underwriting essential real estate transactions, this acquisition presented the right opportunity to enter Poland and add a valuable new spoke to our growing Pan-European platform.”

Pepijn Morshuis, CEO of Trei Real Estate, added: “We are big believers in the further growth of retail parks and convenience retail in Poland. With ownership of Trei increasingly focusing on the USA, however, in Ares and Slate we found good and trusted new owners of our beloved Vendo Parks, enabling us to pursue other opportunities in the far west.”

Ares Real Estate is one of the world’s most scaled and diversified vertically integrated real estate managers, having grown organically and through the acquisitions of GCP International, Black Creek Group and Walton Street Mexico. Today, Ares Real Estate has more than 740 team members globally and manages a portfolio representing more than 720 million square feet. Ares Real Estate had $108.7 billion of assets under management, as of June 30, 2025.

Slate has been an active investor in the European real estate market since 2016, transacting on more than 1,000 commercial properties across nine countries. In 2025 alone, Slate has completed over €1 billion of essential real estate acquisitions across Europe. The firm maintains a distinct focus on essential real estate, concentrating on the acquisition, ownership, and operation of assets vital to daily life, including grocery stores, necessity-based retail centers, and the logistics infrastructure that supports the distribution of food and other non-discretionary goods. This acquisition marks Slate’s first investment in Poland and further increases the firm’s exposure to high-quality essential real estate in Europe.

The transaction is expected to close by December 31st, 2025, subject to customary and regulatory approvals. Rymarz Zdort Maruta, CBRE, PwC, and Gleeds advised Ares and Slate.

About Ares Management Corporation
Ares Management Corporation (NYSE: ARES) is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, real estate, private equity and infrastructure asset classes. We seek to advance our stakeholders’ long-term goals by providing flexible capital that supports businesses and creates value for our investors and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of June 30, 2025, Ares Management Corporation's global platform had over $572 billion of assets under management, with operations across North America, South America, Europe, Asia Pacific and the Middle East. For more information, please visit www.aresmgmt.com.

About Slate Asset Management
Slate Asset Management is a global investor and manager focused on essential real estate and infrastructure assets. We focus on fundamentals with the objective of creating long-term value for our investors and partners across the real assets space. We are supported by exceptional people and flexible capital, which enable us to originate and execute on a wide range of compelling investment opportunities. Visit slateam.com to learn more, and follow Slate Asset Management on LinkedIn, X (Twitter), and Instagram.

About Trei Real Estate
Trei Real Estate GmbH, a German real estate company with registered office in Düsseldorf, acquires, develops and manages customized and sustainable residential and retail properties. As a wholly-owned subsidiary of the Tengelmann Group, it focuses on real estate investments and developments in Germany, Poland and the United States. For more details, go to www.treirealestate.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251028502882/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Compass Pathways to Announce Third Quarter Financial Results on November 4, 202528.10.2025 11:30:00 CET | Press release

Compass management will host a conference call at 8:00 am ET (1:00 pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter ended September 30, 2025, and provide an update on recent developments, on November 4, 2025. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 4, 2025. A live webcast of the call will be available on the Compass Pathways website at: https://events.q4inc.com/attendee/698442687. The webcast will be archived for 30 days. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pionee

BeOne Medicines to Present at Upcoming Investor Conferences28.10.2025 11:01:00 CET | Press release

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in fireside chats at two upcoming investor conferences: Guggenheim Second Annual Healthcare Innovation Conference on Monday, November 10, 2025 at 9:30 am EST; and Jefferies Global Healthcare Conference in London on Monday, November 17, 2025 at 4:00 pm GMT/11:00 am EST Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through

Allianz Reports Safety Gains From Automated Mobility and Urges EU-Wide “Driving License” for Autonomous Vehicles28.10.2025 10:05:00 CET | Press release

Strategic priorities for safe autonomous mobility: Allianz calls for EU-wide uniform testing standards for the approval of autonomous vehicles, free access to accident- and safety-related in-vehicle data, and a joint European database for critical traffic situations.Predicted Safety Improvements: Allianz forecasts a 20 percent reduction in traffic accidents by 2035, increasing to over 50 percent by 2060, thanks to autonomous technology.Allianz claims analysis confirms that currently available autonomous braking assistance systems reduce the frequency of specific accidents by 66 percent.Consumer confidence and concerns: A survey across seven European countries reveals that while consumers expect safety improvements, they remain cautious about technological maturity and reliability.Victim protection is essential: Current liability and compulsory insurance models in motor insurance across most EU countries are suitable for autonomous vehicles. The promise of autonomous mobility is not jus

SK pharmteco Achieves Highest-Level My Green Lab Certifications Across Europe and Asia28.10.2025 09:00:00 CET | Press release

Green certification is the top tier of the globally recognized My Green Lab program for laboratory sustainability excellence SK pharmteco, a global contract development and manufacturing organization (CDMO), today announced a significant milestone in its commitment to environmental sustainability by earning four My Green Lab certifications, including two at the program’s highest level, Green. The remaining two labs earned Gold certification, reflecting advanced sustainability performance and progression toward full Green maturity. The certified facilities are Small Molecule Europe (Swords, Ireland) and Small Molecule Asia (Daejeon, South Korea), and the certifications cover the areas of Quality Control, Process Research & Development, and Analytical Research & Development. My Green Lab certification is widely regarded as the global standard for laboratory sustainability, recognized by the United Nations Race to Zero campaign for its rigor in advancing credible decarbonization. Green ce

Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspection for Commercial Drug-Product Manufacturing28.10.2025 07:00:00 CET | Press release

Milestone expands India’s role in global biologics manufacturing; collaboration with Cipla underscores commitment to quality and reliability Kemwell Biopharma Pvt Ltd (“Kemwell”), a leading global biologics Contract Development and Manufacturing Organization (CDMO), announced today that its drug-product manufacturing facility in Bengaluru has successfully completed a U.S. Food and Drug Administration (FDA) pre-approval inspection (PAI) and is now cleared for the commercial manufacturing and testing of injectable products destined for the U.S. market. This milestone marks the approval of the first product to get U.S. FDA clearance for commercial supply from Kemwell’s Bengaluru drug-product facility since the site became a dedicated biologics campus eight years ago. It demonstrates the company’s ability to meet stringent current Good Manufacturing Practice (cGMP) and aseptic drug-product manufacturing standards. “Achieving FDA clearance for commercial manufacturing from our Bengaluru sit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye